President Trump’s proposed tariffs on Denmark could have costly consequences for Americans relying on GLP-1 medications like ...

The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

He spoke on the chances of getting popular weight loss drugs like Saxenda and Wegovy covered again for state employees, future premium increases and more. Briner announced soon after taking office ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...